Prosecution Insights
Last updated: April 19, 2026

Kadmon Corporation LLC

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18434994 Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase MCDOWELL, BRIAN E 1624 Final Rejection Feb 07, 2024
18548678 USE OF DIHYDROOROTATE DEHYDROGENASE (DHODH) INHIBITORS TO TARGET FERROPTOSIS IN CANCER THERAPY MCANANY, JOHN D 1625 Non-Final OA Sep 01, 2023
18104364 Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase ANDERSON, REBECCA L 1626 Final Rejection Feb 01, 2023
18059548 B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion Proteins LU, CHENG 1642 Non-Final OA Nov 29, 2022

Managing Kadmon Corporation LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month